Triggering role of nitric oxide in the delayed protective effect of monophosphoryl lipid A in rat heart

British Journal of Pharmacology

Volumn 127, Issue 8, 1999, Pages 1892-1898

  György, Katalin ^a   Muller, Bernard ^a   Végh, Agnes ^b   Kleschyov, Andrei L ^a   Stoclet, Jean Claude ^a  

^a CNRS   (France)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cardioprotection; Inducible no synthase; Monophosphoryl lipid A; Nitric oxide; Spin trapping

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHORYL LIPID A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AORTA, THORACIC; LIPID A; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NOREPINEPHRINE; RATS; RATS, WISTAR; SPIN TRAPPING; VASOCONSTRICTOR AGENTS; VENTRICULAR FUNCTION;

EID: 0032810299     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702725     Document Type: Article

References (28)

1. Baxter, G.F., Goodwin, R.W., Wright, M.J., Kerac, M., Heads, R.J. & Yellon, D.M. (1996). Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart. Br. J. Pharmacol., 117, 1685-1692.
2. Bolli, R., Manchikalapudi, S., Tang, X-L., Takano, H., Qiu, Y., Guo, Y., Zhang, Q. & Jadoon, A.K. (1997). The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Circ. Res., 81, 1094-1107.
3. Brown, J.M., Grosso, M.A., Terada, L.S., Whitman, G.J.R., Banerjee, A., White, C.W., Harken, A.H. & Repine, J.E. (1989). Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischaemia-reperfusion injury of isolated rat hearts. Proc. Natl. Acad. Sci., 86, 2516-2520.
4. Connor, J.R., Manning, P.T., Settle, S.L., Moore, W.M., Jerome, G.M., Webber, R.K., Tjoeng, F.S. & Currie, M.G. (1995). Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol., 273, 15-24.
5. Elliott, G.T. (1998). Monophosphoryl lipid A induces delayed preconditioning against cardiac ischaemia-reperfusion injury. J. Mol. Cell. Cardiol., 30, 3-17.
6. Elliott, G.T., Comerford, M.L., Smith, J.R. & Zhao, L. (1996). Myocardial ischaemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide. Cardiovasc. Res., 32, 1071-1080.
7. Griffiths, M.J.D., Messent, M., Macallister, R.J. & Evans, T.W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 11, 963-968.
8. Hasan, K., Heesen, B.-J., Corbett, J.A., McDaniel, M.L., Chang, K., Allison, W., Wolffenbuttel, B.H.R., Williamson, J.R. & Tilton, R.G. (1993). Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol., 249, 101-106.
9. Malyshev, I.Y., Malugin, A.V., Manukhina, E.B., Larionov, N.P., Malenyuk, E.B., Malysheva, E.V., Mikoyan, V.D. & Vanin, A.F. (1996). Is HSP70 involved in nitric oxide-induced protection of the heart? Physiol. Res., 45, 267-272.
10. Misko, T.P., Moore, W.M., Kasten, T.P., Nickols, G.A., Corbett, J.A., Tilton, R.G., McDaniel, M.L., Williamson, J.R. & Currie, M.G. (1993). Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 233, 119-125.
11. Moore, W.M., Webber, R.K., Jerome, G.M., Tjoeng, F.S., Misko, T.P. & Currie, M.G. (1994). L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem., 37, 3886-3888.
12. Mülsch, A., Mordvintcev, P., Bassenge, E., Lung, F., Clement, B. & Busse, R. (1995). In vivo spin trapping of glycerol trinitrate-derived nitric oxide in rabbit blood vessels and organs. Circulation, 92, 1876-1882.
13. Nayeem, M.A., Elliott, G.T., Shah, M.R., Hastillo-Hess, S.L. & Kukreja, R.C. (1997). Monophosphoryl lipid A protects adult rat cardiomyocytes with specific induction of the 72-KD heat shock protein. J. Mol. Cell. Cardiol., 29, 2303-2310.
14. Nelson, D.W., Brown, J.M., Banerjee, A., Bensard, D.D., Rogers, K.B., Locke-Winter, C.R., Anderson, B.O. & Harken, A.H. (1991). Pretreatment with a nontoxic derivative of endotoxin induces functional protection against cardiac ischemia/reperfusion injury. Surgery, 110, 365-369.
15. Ribi, E. (1984). Beneficial modification of the endotoxin molecule. J. Biol. Response Modif., 3, 1-9.
16. Richard, V., Kaeffer, N. & Thuillez, C. (1996). Delayed protection of the ischaemic heart - from pathophysiology to therapeutic applications. Fundam. Clin. Pharmacol., 10, 409-415.
17. Sano, H., Hirai, M., Saito, H., Nakashima, I. & Isobe, K. (1996). Nitric oxide releasing reagent, S-nitroso-N-acetylpenicillamine, enhances the expression of manganese superoxide dismutase mRNA in rat vascular smooth muscle cells. J. Cell. Biochem., 62, 50-55.
18. Song, W., Furman, B.L. & Parratt, J.R. (1998). Monophosphoryl lipid A reduces both arrhythmia severity and infaret size in a rat model of ischaemia. Eur. J. Pharmacol., 345, 285-287.
19. Southan, G.J. & Szabo, C. (1996). Selective pharmacological inhibition of distinct nitric oxide synthases with variable isoforms selectivity. Biochem. Pharmacol., 51, 383-394.
20. Tosaki, A., Maulik, N., Elliott, G.I., Blasig, L.E., Engelman, R.M. & Das, D.K. (1998). Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J. Pharmacol. Exp. Ther., 285, 1274-1279.
21. Vanin, A.F., Mordvintcev, P.I. & Kleschyov, A.L. (1984). Appearance of nitrogen oxide in animal tissues in vivo. Stud. Biophys., 102, 135-143.
22. Vėgh, A., Papp, J.GY., Elliott, G.T. & Parratt, J.R. (1996). Pretreatment with monophosphoryl lipid A (MPL-C) reduces ischaemia reperfusion-induced arrhythmias in dogs. J. Mol. Cell. Cardiol., 28, A56 (abstract).
23. Wang, P. & Zweier, J.L. (1996). Measurement of nitric oxide and peroxynitrite generation in the postischaemic heart: evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem., 271, 29223-29230.
24. Yang, B.C., Chen, L.Y., Saldeen, T.G.P. & Mehta, J.L. (1997). Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxide. Br. J. Pharmacol., 120, 305-311.
25. Yao, Z., Auchampach, J.A., Pieper, G.M. & Gross, G.J. (1993a). Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analog, in the dog. Cardiovasc. Res., 27, 832-838.
26. Yao, Z., Rasmussen, J.L., Hirt, J.L., Mei, D.A., Pieper, G.M. & Gross, G.J. (1993b). Effects of monophosphoryl lipid A on myocardial ischaemia/reperfusion injury in dogs. J. Cardiovasc. Pharmacol., 22, 653-663.
27. Yasmin, W., Strynadka, K.D. & Schulz, R. (1997). Generation of peroxynitrite contributes to ischaemia-reperfusion injury in isolated rat hearts. Cardiovasc. Res., 33, 422-432.
28. Zhao, L., Weber, P.A., Smith, J.R., Comerford, M.L. & Elliott, G.T. (1997). Role of inducible nitric oxide synthase in pharmacological 'preconditioning' with monophosphoryl lipid A. J. Mol. Cell. Cardiol., 29, 1567-1576.